Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,190 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06927271Recruiting
Phone or video support to help with blood pressure medicine
This trial tests if regular phone calls or video chats can help people with high blood pressure take their medicine as prescribed. It aims to see if these check-ins improve blood pressure control.
Efiduase, KoforiduaAges 18–65 - NCT06951308Recruiting
Carb loading for type 2 diabetes before bypass surgery
This trial tests whether giving a carbohydrate drink before heart bypass surgery helps control blood sugar in people with type 2 diabetes. If it works, it could make recovery smoother.
DamascusAges Any age - NCT06953180Recruiting
Epigenetics, aging, and disease prevention study in Kazakhstan
This study looks at how your genes and environment affect your risk for non-communicable diseases like heart disease or diabetes. It aims to predict your biological age and help create personalized prevention plans.
Almaty, KazakhstanAges 18–69 - NCT06959277Recruiting
Walkasins study for balance with peripheral neuropathy
This trial tests if a wearable device called Walkasins can improve balance and walking in people with peripheral neuropathy. It may help if you have trouble with balance and your foot size fits the device.
Mesa, ArizonaAges 55 years+ - NCT06989164Recruiting
How Your Body Responds to Different Foods After Eating
This study looks at how different foods affect your body after eating, especially your blood sugar and other metabolic responses. It may help find personalized ways to eat better for your health.
Stanford, CaliforniaAges 18–80 - NCT07027995Recruiting
Food and Fitness with Medicine
This study tests a program that combines nutrition counseling, online grocery support, and exercise sessions for people taking GLP-1 medications. It aims to help manage conditions like high blood pressure, diabetes, high cholesterol, kidney disease, or metabolic syndrome.
Columbus, OhioAges 18 years+ - NCT07065383Recruiting
Testing a drug and exercise for heart and muscle fat in diabetes
This study tests if a weekly injection (semaglutide) combined with an exercise program can help reduce fat stored in the heart and muscles in people with type 2 diabetes. It may improve how well your body handles sugar and lowers your risk for heart problems.
Aberdeen, AberdeenshireAges 20–75 - NCT07072234RecruitingPhase 1
CAR NK cell therapy for advanced clear cell kidney cancer
This trial tests a new type of immune cell therapy (CAR NK cells) that targets a protein called CD70 on kidney cancer cells. It's for people with advanced clear cell kidney cancer that hasn't responded to standard treatments.
Houston, TexasAges 18 years+ - NCT07106879Recruiting
Pre-screening for future metabolic and psychiatric studies
This study does not test a new treatment. It is a pre-screening program to see if you might qualify for future clinical trials on metabolic conditions (like diabetes or weight issues) or psychiatric health (like depression or anxiety). You will be asked some questions and may do some basic health checks to see which future trials could be a good fit for you.
Brooklyn, New YorkAges 18 years+ - NCT07126587Recruiting
Healthy Living in Anson County Study
This study offers healthy meals and group classes to help people in Anson County manage or prevent chronic diseases like diabetes and high blood pressure. You'll learn about and try a Mediterranean diet, which is known to be good for heart health.
Chapel Hill, North CarolinaAges 18–99 - NCT07128186Recruiting
AI predicts memory decline in type 2 diabetes
This study uses an AI tool to predict memory problems in people with type 2 diabetes. It may help catch early signs of cognitive decline and guide future care.
Enshi, HubeiAges 40–75 - NCT07140848Recruiting
CGM-enhanced program to prevent type 2 diabetes in prediabetes
This trial tests whether adding continuous glucose monitors (CGMs) to a proven lifestyle program helps adults with prediabetes prevent type 2 diabetes. You'll attend coaching sessions and wear a small sensor to track your blood sugar.
Buffalo, New YorkAges 18 years+ - NCT07187830Recruiting
Semaglutide for belly fat and liver health in kidney disease
This study looks at whether semaglutide (a diabetes medication) affects belly fat and the liver in people who have both type 2 diabetes and chronic kidney disease. It aims to understand if the drug can improve these health markers even in patients with reduced kidney function.
Edmonton, AlbertaAges 18 years+ - NCT07220213Recruiting
Fellowship to better health for Black men
This study tests a program to help Black men improve their heart health. It focuses on lifestyle changes like diet and physical activity.
Birmingham, AlabamaAges 18 years+ - NCT07246421Recruiting
Glucagon resistance in fatty liver and diabetes
This study looks at how people with fatty liver and type 2 diabetes respond to glucagon, a hormone that helps control blood sugar. It may help researchers understand a condition called 'glucagon resistance' and find better treatments.
AarhusAges 30–70 - NCT06750497Recruiting
Arm immobilization study in type 2 diabetes
This study tests how a short period of arm immobilization (like wearing a cast) affects muscle health in people with and without type 2 diabetes. It may help researchers understand muscle changes in diabetes.
Wageningen, GelderlandAges 18–80 - NCT07254689Recruiting
Food for Health: A diabetes nutrition study for Native American elders
This study tests if a food program can help older Native American adults on the Flathead Reservation who have diabetes or are at risk for it. It looks at how better nutrition affects health.
Arlee, MontanaAges 55 years+ - NCT07279194RecruitingPhase 3
Study of HDM1005 for weight loss in Chinese adults without diabetes
This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.
ShanghaiAges 18 years+ - NCT07282600RecruitingPhase 3
Study of eloralintide for type 2 diabetes and weight
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
Birmingham, AlabamaAges 18 years+ - NCT07296276Recruiting
Testing the CareSens Air 3 glucose monitor in type 1 diabetes
This study tests how accurate a new continuous glucose monitor (CGM) called CareSens Air 3 is for adults with type 1 diabetes. You would wear the sensor on your skin to track blood sugar levels, and it may help you manage your diabetes more easily.
Escondido, CaliforniaAges 18–65 - NCT07300293Recruiting
Metformin and lactic acidosis in intensive care
This study looks at patients in intensive care who had lactic acidosis, to see if taking metformin before admission played a role. It may help understand how metformin affects recovery.
StrasbourgAges 18 years+ - NCT07314684RecruitingPhase 4
Semaglutide's effect on inflammation in type 2 diabetes
This study tests whether the diabetes medication semaglutide can reduce inflammation and improve blood vessel health in people with type 2 diabetes who have no significant heart artery blockages. If you have diabetes and are at moderate to high heart risk but haven't had heart problems, this could help understand the medicine's extra benefits beyond blood sugar control.
Caserta, CasertaAges 18–85 - NCT07024823RecruitingPhase 1
Safety study of AZD4248 in healthy people and those with kidney disease and diabetes
This trial tests an experimental drug called AZD4248 to see if it's safe for healthy people and for people with chronic kidney disease and type 2 diabetes. It also checks if a home device can accurately measure kidney function.
Glendale, CaliforniaAges 18–75 - NCT07678671Enrolling by invitation
Diabetes education program for blood sugar control
This study tests whether an educational program called Ask Me 3® helps people with type 2 diabetes manage their blood sugar. It’s for adults who get care at a specific clinic.
San Nicolás de los Garza, Nuevo LeónAges 18–80
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,190 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.